Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma

Allergy. 2024 Aug;79(8):2244-2247. doi: 10.1111/all.16011. Epub 2024 Jan 10.

Authors

Pieter-Paul Hekking^{1

2}, Kayla Zhang¹, Carmen Paz Venegas Garrido¹, Raquel Lopez-Rodriguez^{1

3}, Melanie Kjarsgaard¹, Manali Mukherjee¹, Parameswaran Nair¹

Affiliations

¹ Division of Respirology, Department of Medicine, St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada.
² Department of Respiratory Diseases, STZ Centre of Excellence for Asthma & COPD, Franciscus Gasthuis & Vlietland Hospital, Rotterdam, The Netherlands.
³ Department of Allergy, Lucus Augusti Hospital, Lugo, Spain.

PMID: 38197516
DOI: 10.1111/all.16011

No abstract available

Publication types

Letter

MeSH terms

Anti-Asthmatic Agents / therapeutic use
Asthma* / drug therapy
Asthma* / immunology
Asthma* / metabolism
Biological Therapy / methods
Cytokines* / metabolism
Female
Humans
Interleukin-5* / antagonists & inhibitors
Male
Middle Aged
Nitric Oxide / metabolism
Severity of Illness Index
Sputum*

Substances

Cytokines
Interleukin-5
Nitric Oxide
Anti-Asthmatic Agents